Cargando…

T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival

Idiopathic pulmonary fibrosis (IPF) is a devastating disease that kills as many Americans as breast cancer each year. This study investigated whether lung function decline and survival associates with adaptive immunity in patients with IPF, specifically the expression of checkpoint molecules ICOS, C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonham, Catherine A., Hrusch, Cara L., Blaine, Kelly M., Manns, Stephenie T., Vij, Rekha, Oldham, Justin M., Churpek, Matthew M., Strek, Mary E., Noth, Imre, Sperling, Anne I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243672/ https://www.ncbi.nlm.nih.gov/pubmed/32455343 http://dx.doi.org/10.1016/j.yrmex.2019.100002

Ejemplares similares

Skewed Lung CCR4 to CCR6 CD4(+) T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s
por: Hrusch, Cara L., et al.
Publicado: (2017)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis
por: Adegunsoye, Ayodeji, et al.
Publicado: (2017)

Idiopathic Pulmonary Fibrosis Genetic Risk Factors, Function, and Mechanisms? The Concepts Are Starting to Gel
por: Bonham, Catherine A., et al.
Publicado: (2022)

A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis
por: Huang, Yong, et al.
Publicado: (2015)

Automated CT Analysis of Major Forms of Interstitial Lung Disease
por: Crews, Marlee S., et al.
Publicado: (2020)

Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease
por: Biblowitz, Kathleen, et al.
Publicado: (2021)

N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia
por: Oldham, Justin M., et al.
Publicado: (2018)

Transcriptional programming and T cell receptor repertoires distinguish human lung and lymph node memory T cells
por: Schoettler, Nathan, et al.
Publicado: (2019)

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
por: Adegunsoye, Ayodeji, et al.
Publicado: (2017)

Clinical course and management of idiopathic pulmonary fibrosis
por: Quinn, Caitlin, et al.
Publicado: (2019)

Inducible co-stimulatory molecule (ICOS) alleviates paclitaxel-induced neuropathic pain via an IL-10-mediated mechanism in female mice
por: Sankaranarayanan, Ishwarya, et al.
Publicado: (2023)

Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
por: Chung, Jonathan H., et al.
Publicado: (2021)

Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
por: Zhang, David, et al.
Publicado: (2023)

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
por: Bouwhuis, Marna G., et al.
Publicado: (2009)

ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020)

Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis
por: Huang, Yong, et al.
Publicado: (2023)

Role of endocytosis and trans‐endocytosis in ICOS costimulator‐induced downmodulation of the ICOS Ligand
por: Aragoneses‐Fenoll, Laura, et al.
Publicado: (2021)

T cell co-stimulator inducible co-stimulatory (ICOS) exerts potential anti-atherosclerotic roles through downregulation of vascular smooth muscle phagocytosis and proliferation
por: Zhong, Zhixiong, et al.
Publicado: (2020)

Colloque ICO '89
por: Moulin, B, et al.
Publicado: (1989)

Protective Effector Memory CD4 T Cells Depend on ICOS for Survival
por: Moore, Tamson V., et al.
Publicado: (2011)

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020)

Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts
por: Adegunsoye, Ayodeji, et al.
Publicado: (2023)

Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing
por: Lorenzo-Salazar, Jose M., et al.
Publicado: (2019)

ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
por: O’Brien, Carleigh A., et al.
Publicado: (2020)

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
por: Pawlak-Adamska, Edyta, et al.
Publicado: (2016)

Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations
por: Leavy, Olivia C., et al.
Publicado: (2021)

Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
por: Rujas, Edurne, et al.
Publicado: (2020)

Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4
por: Botturi, Karine, et al.
Publicado: (2011)

Inhibition of Donor-Reactive CD8+ T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression
por: Liu, Danya, et al.
Publicado: (2015)

Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
por: Pawlak-Adamska, Edyta, et al.
Publicado: (2017)

Specific transcriptional programs differentiate ICOS from CD28 costimulatory signaling in human Naïve CD4(+) T cells
por: Gigliotti, Casimiro Luca, et al.
Publicado: (2022)

Regulation of T follicular helper cells by ICOS
por: Hutloff, Andreas
Publicado: (2015)

ICOS regulates ILC2s in asthma
por: Maazi, Hadi, et al.
Publicado: (2015)

ICOS Co-Stimulation: Friend or Foe?
por: Wikenheiser, Daniel J., et al.
Publicado: (2016)

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
por: Orvain, Cindy, et al.
Publicado: (2022)

Targeting the ICOS/ICOS‐L pathway in a mouse model of established allergic asthma disrupts T follicular helper cell responses and ameliorates disease
por: Uwadiae, Faith I., et al.
Publicado: (2018)

Tokenomics: the crypto shift of blockchains, ICOs, and tokens
por: Au, Sean, et al.
Publicado: (2018)

International trends in optics and photonics: ICO IV
por: Asakura, Toshimitsu
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_ds9arojcj8v3rpn3bcfrjguuia